Drug
Merional
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Other(4)
Detailed Status
unknown4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 33 (100.0%)
Trials by Status
unknown4100%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_3
Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility
NCT02469805
unknownphase_3
Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis
NCT02470169
unknownphase_3
Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility
NCT02461173
unknown
The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS
NCT02673632
Clinical Trials (4)
Showing 4 of 4 trials
NCT02469805Phase 3
Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility
NCT02470169Phase 3
Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis
NCT02461173Phase 3
Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility
NCT02673632
The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4